The Central Virginia Center on Drug Abuse Research
弗吉尼亚中部药物滥用研究中心
基本信息
- 批准号:9189703
- 负责人:
- 金额:$ 59.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-12-01 至 2018-11-30
- 项目状态:已结题
- 来源:
- 关键词:Analytical ChemistryAnimalsAreaBehaviorBiomedical ResearchBody FluidsBreedingCardiovascular systemChemicalsChemistryCollaborationsCore GrantCountryDiseaseDrug AddictionDrug abuseEndocannabinoidsEnvironmentEquipmentFacultyForensic MedicineFundingFunding OpportunitiesFutureGene ExpressionGeneticGenetic EngineeringGenotypeGoalsGrantHumanImageInstitutionIon ChannelKnowledgeLaboratoriesLettersLipidsMethodologyMolecular GeneticsMusNational Institute of Drug AbuseOpioidPaperPharmaceutical PreparationsPharmacology and ToxicologyPharmacy SchoolsPilot ProjectsProductivityPublishingRecording of previous eventsRecruitment ActivityResearchResearch PersonnelResearch Project GrantsResourcesScientistSignal TransductionSocietiesSubstance AddictionSubstance abuse problemSynthesis ChemistryTechnologyTimeTissuesToxicologyTrainingTransgenic OrganismsUniversitiesUpdateViral VectorVirginiaWorkcravingexperiencegastrointestinalinnovationinterestnovelplanetary Atmospherepreventprogramspublic health relevanceranpirnasereceptor functionsuccesstool
项目摘要
DESCRIPTION (provided by applicant): The overall aim of this Center is to provide molecular, genetic, chemical and analytical knowledge and expertise to create new and enhance previously funded drug abuse research at this and neighboring universities. These Cores will provide up-to-date and innovative expertise that is somewhat oblique to the methodologies used in previously funded research. This will result in new collaborative research and enhance previously funded research in ways that could not have been contemplated just a few years ago. Cores in synthetic and analytical chemistry, genetics, genetically engineered altered mice/viral vectors, and receptor function will provide the opportunity for funded researchers to broaden the scope of their work to transform knowledge in very creative ways. The inclusion of chemistry, genetics and analytical Cores will fill a major void in our many research projects. The ability to continue to provide genetically altered mice with appropriate genotyping, etc., and the inclusion of expertise in viral vector technology are seen as major assets of this Center. Being able to have a collaborator elucidate receptor function changes for a substance found to alter behavior or craving for a drug provides the atmosphere for new and creative research. This type of collaboration among scientists at different institutions is rare and would take many months or years if in fact collaboration could be established at all. In this Center this type of collaboratin will be the norm. We are committed to provide considerable institutional support such as the use of an up-to-date imaging center and a forensic toxicology laboratory established by the university. We will match dollar for dollar the pilot project program and provide administrative support beyond the modest amount requested. The Cores will also be utilized by NlDA-funded investigators at the University of Virginia and George Mason University. Scholars at the relatively new Pharmacy School at Hampton University have expressed interest (letter from the dean) in the utilization of these Cores as they establish their research programs. We will also share all aspects of this Center with scientists throughout the country.
描述(由申请人提供):该中心的总体目的是提供分子,遗传,化学和分析知识和专业知识,以在该大学和邻近的大学中创建新的和增强先前资助的药物滥用研究。这些核心将提供最新和创新的专业知识,这与先前资助的研究中使用的方法有些倾斜。这将导致新的合作研究,并以几年前本来可以预见的方式增强了以前资助的研究。合成和分析化学,遗传学,基因工程改变的小鼠/病毒载体以及受体功能的核心将为资助的研究人员提供机会扩大其工作范围,以非常有创造力的方式改变知识。化学,遗传学和分析核心的纳入将填补我们许多研究项目的主要空隙。继续提供适当的基因分型等的遗传改变的小鼠的能力,并且在病毒载体技术中包含专业知识是该中心的主要资产。能够让合作者阐明受体功能的变化,以改变一种改变行为或渴望药物的物质,为新的创意研究提供了氛围。不同机构的科学家之间的这种合作很少见,如果实际上可以建立合作,则需要数月或几年的时间。在这个中心,这种类型的协作将是常态。我们致力于提供大量的机构支持,例如使用最新成像中心和大学建立的法医毒理学实验室。我们将与Dollar相匹配“飞行员项目计划”计划,并提供超出所需金额的管理支持。 NLDA资助的弗吉尼亚大学和乔治·梅森大学的调查员还将使用核心。汉普顿大学相对较新的药学学校的学者在建立研究计划时对这些核心的利用表示了兴趣(院长的信)。我们还将与全国各地的科学家分享该中心的所有方面。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William L. Dewey其他文献
Derivatives of Apomorphine and of Other <em>N</em>-Substituted Norapomorphines
- DOI:
10.1002/jps.2600651129 - 发表时间:
1976-11-01 - 期刊:
- 影响因子:
- 作者:
Edward R. Atkinson;S.P. Battista;Istvan E. Ary;Donald G. Richardson;Louis S. Harris;William L. Dewey - 通讯作者:
William L. Dewey
Excretion of <em>trans</em>-Δ<sup>9</sup>-Tetrahydrocannabinol and Its Metabolites in Intact and Bile Duct-Cannulated Rats
- DOI:
10.1002/jps.2600620506 - 发表时间:
1973-05-01 - 期刊:
- 影响因子:
- 作者:
Robert F. Turk;Louis S. Harris;William L. Dewey - 通讯作者:
William L. Dewey
Mo1598 - Colonic Supernatants from Chronic Morphine Exposed Mice Induce Morphine Tolerance in Naïve Dorsal Root Ganglion Neurons that is Mitigated by Oral Vancomycin Delivery
- DOI:
10.1016/s0016-5085(17)32537-4 - 发表时间:
2017-04-01 - 期刊:
- 影响因子:
- 作者:
Ryan Mischel;William L. Dewey;Hamid I. Akbarali - 通讯作者:
Hamid I. Akbarali
Mo1578 - The Effect of a G-Protein Biased Ligand, TRV130, on Opioid-Induced Constipation
- DOI:
10.1016/s0016-5085(18)32629-5 - 发表时间:
2018-05-01 - 期刊:
- 影响因子:
- 作者:
Joanna C. Jacob;Bethany David;Aliyeen Khan;William L. Dewey;Hamid I. Akbarali - 通讯作者:
Hamid I. Akbarali
Mo1539 - μ-Opioid Receptors Co-Expressed in Cholinergic Neurons of Mouse Ileum Myenteric Plexus Develop Tolerance to Chronic Morphine Exposure
- DOI:
10.1016/s0016-5085(17)32478-2 - 发表时间:
2017-04-01 - 期刊:
- 影响因子:
- 作者:
Karan Muchhala;Aravind Gade;William L. Dewey;Hamid I. Akbarali - 通讯作者:
Hamid I. Akbarali
William L. Dewey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William L. Dewey', 18)}}的其他基金
The Central Virginia Center on Drug Abuse Research
弗吉尼亚中部药物滥用研究中心
- 批准号:
10604263 - 财政年份:2013
- 资助金额:
$ 59.74万 - 项目类别:
The Central Virginia Center on Drug Abuse Research
弗吉尼亚中部药物滥用研究中心
- 批准号:
10374821 - 财政年份:2013
- 资助金额:
$ 59.74万 - 项目类别:
The Central Virginia Center on Drug Abuse Research
弗吉尼亚中部药物滥用研究中心
- 批准号:
8552155 - 财政年份:2013
- 资助金额:
$ 59.74万 - 项目类别:
The Role of Protein Kinase C in Opioid Tolerance
蛋白激酶 C 在阿片类药物耐受中的作用
- 批准号:
7278267 - 财政年份:2006
- 资助金额:
$ 59.74万 - 项目类别:
The Role of Protein Kinase C in Opioid Tolerance
蛋白激酶 C 在阿片类药物耐受中的作用
- 批准号:
7465564 - 财政年份:2006
- 资助金额:
$ 59.74万 - 项目类别:
The Role of Protein Kinase C in Opioid Tolerance
蛋白激酶 C 在阿片类药物耐受性中的作用
- 批准号:
7148489 - 财政年份:2006
- 资助金额:
$ 59.74万 - 项目类别:
The Role of Protein Kinase C in Opioid Tolerance
蛋白激酶 C 在阿片类药物耐受中的作用
- 批准号:
7652489 - 财政年份:2006
- 资助金额:
$ 59.74万 - 项目类别:
相似国自然基金
臂旁核区域损伤致长时程“昏迷样”动物模型建立及神经机制研究
- 批准号:81901068
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
三江源大型野生食草动物对区域草畜平衡状态影响及管控机制研究
- 批准号:41971276
- 批准年份:2019
- 资助金额:58 万元
- 项目类别:面上项目
基于组蛋白H3K9me3和DNA甲基化修饰协同作用研究早期胚胎发育过程中基因印记区域的调控
- 批准号:31801059
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
使用三代测序技术研究线粒体DNA非编码区域对其DNA复制和转录的调控
- 批准号:31701089
- 批准年份:2017
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
转录因子Msx1与哺乳动物上腭发育的前-后区域化
- 批准号:31771593
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Structurally engineered furan fatty acids for the treatment of dyslipidemia and cardiovascular disease
结构工程呋喃脂肪酸用于治疗血脂异常和心血管疾病
- 批准号:
10603408 - 财政年份:2023
- 资助金额:
$ 59.74万 - 项目类别:
Determinants of age-induced hearing loss and reversal strategies
年龄引起的听力损失的决定因素和逆转策略
- 批准号:
10496280 - 财政年份:2023
- 资助金额:
$ 59.74万 - 项目类别:
Health Effects of the Fluorinated Pollutants; PFAS on Enamel Development
氟化污染物对健康的影响;
- 批准号:
10697298 - 财政年份:2023
- 资助金额:
$ 59.74万 - 项目类别:
Consortium of Research Advancement Facilities and Training
研究进步设施和培训联盟
- 批准号:
10594452 - 财政年份:2022
- 资助金额:
$ 59.74万 - 项目类别: